1. Home
  2. Analysis
  3. Aranesp
  4. Oropharyngeal-blistering

Aranesp and Oropharyngeal blistering - a phase IV clinical study of FDA data

Summary:

Oropharyngeal blistering is reported as a side effect among people who take Aranesp (darbepoetin alfa), especially for people who are female, 60+ old, also take Renagel, and have Limb discomfort.

The phase IV clinical study analyzes which people have Oropharyngeal blistering when taking Aranesp. It is created by eHealthMe based on reports of 54,218 people who have side effects when taking Aranesp from the FDA, and is updated regularly.

What is Aranesp?

Aranesp has active ingredients of darbepoetin alfa. It is often used in anemia. eHealthMe is studying from 54,331 Aranesp users. Check the latest studies of Aranesp.

What is Oropharyngeal blistering?

Oropharyngeal blistering (blister of oropharynx) is found to be associated with 261 drugs and 439 conditions by eHealthMe. Check the latest studies of Oropharyngeal blistering.

On Jun, 17, 2026

54,218 people reported to have side effects when taking Aranesp.
Among them, 21 people (0.04%) have Oropharyngeal blistering.

Could Aranesp cause Oropharyngeal blistering?

Among these 21 people:

What is the gender of people who have Oropharyngeal blistering when taking Aranesp? *

  • female: 85.71 %
  • male: 14.29 %

What is the age of people who have Oropharyngeal blistering when taking Aranesp? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 14.29 %
  • 60+: 85.71 %

What are other drugs people take besides Aranesp? *

  1. Renagel: 21 people, 100.00%
  2. Neurontin: 18 people, 85.71%
  3. Furosemide: 18 people, 85.71%
  4. Zometa: 18 people, 85.71%
  5. Oxycontin: 18 people, 85.71%
  6. Pamelor: 18 people, 85.71%
  7. Rythmol: 18 people, 85.71%
  8. Aredia: 18 people, 85.71%
  9. Vicodin: 18 people, 85.71%
  10. Vioxx: 18 people, 85.71%

What are other side effects people have besides Oropharyngeal blistering? *

  1. Weakness: 18 people, 85.71%
  2. Impaired Healing: 18 people, 85.71%
  3. Osteolysis (dissolution of bone): 18 people, 85.71%
  4. Osteitis (a general term for inflammation of bone): 18 people, 85.71%
  5. Oral Pain: 18 people, 85.71%
  6. Oedema (fluid collection in tissue): 18 people, 85.71%
  7. Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 18 people, 85.71%
  8. Limb Discomfort (discomfort in leg): 18 people, 85.71%
  9. Joint Injury: 18 people, 85.71%
  10. Intervertebral Disc Protrusion (spinal disc protrusion): 18 people, 85.71%

What are the existing conditions these people have? *

  1. Pain: 18 people, 85.71%
  2. Multiple Myeloma (cancer of the plasma cells): 18 people, 85.71%
  3. Limb Discomfort (discomfort in leg): 18 people, 85.71%
  4. Acute Kidney Failure: 6 people, 28.57%
  5. Muscle Spasms (muscle contraction): 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Aranesp and have Oropharyngeal blistering?

- Check whether Oropharyngeal blistering is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aranesp:

Oropharyngeal blistering treatments and more:

How severe was Oropharyngeal blistering and when was it recovered:

Expand to all the drugs that have ingredients of darbepoetin alfa:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Aranesp:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Oropharyngeal blistering:

Browse all the conditions that are associated with Oropharyngeal blistering:

How the study uses the data?

The study uses data from the FDA. It is based on darbepoetin alfa (the active ingredients of Aranesp) and Aranesp (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.